Latest filing published 26 Aug 2026 for Atara Biotherapeutics, Inc., €35k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by AnhCo Nguyen on record concern Atara Biotherapeutics, Inc. Over a trading history stretching from 16 August 2023 to 17 August 2026, the count stands at 24 filings.
Sales make up the whole of the open-market record (21 sales, €239k). The rest of the record consists of 3 share grants. 2026 to date brings no purchases and 5 sales.
The latest filing, published on 26 August 2026, reports an open-market sale of €35k in Atara Biotherapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
17 of 17 declarations